Hidetoshi Kanai

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death

Kazuhiko Tsuruya, Toshiharu Ninomiya, Masanori Tokumoto et al. · Kidney International · 2003 · 241 citations

Life Sciences, Cell Biology, Nephrology +16

Predominance of Th1 immune response in diffuse proliferative lupus nephritis

Kohsuke Masutani, Mitsuteru Akahoshi, Kazuhiko Tsuruya et al. · Arthritis & Rheumatism · 2001 · 225 citations

Medicine, Immunology, Pathology +17

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dialysis-Related Hypotension as a Cause of Progressive Frontal Lobe Atrophy in Chronic Hemodialysis Patients: A 3-Year Prospective Study

Tohru Mizumasa, Hideki Hirakata, Takahiro Yoshimitsu et al. · Nephron Clinical Practice · 2004 · 118 citations

Medicine, Nephrology, Neurology +16